SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-082531
Filing Date
2024-07-25
Accepted
2024-07-25 09:06:32
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6K azn-20240630x6k.htm   iXBRL 6-K 4457230
7 GRAPHIC azn-20240630x6k001.jpg GRAPHIC 4829
  Complete submission text file 0001104659-24-082531.txt   14086577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA azn-20240630.xsd EX-101.SCH 82240
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azn-20240630_cal.xml EX-101.CAL 93880
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azn-20240630_def.xml EX-101.DEF 253212
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE azn-20240630_lab.xml EX-101.LAB 524022
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azn-20240630_pre.xml EX-101.PRE 372776
58 EXTRACTED XBRL INSTANCE DOCUMENT azn-20240630x6k_htm.xml XML 3233932
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 241140159
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)